187 related articles for article (PubMed ID: 31151136)
1. The extracellular matrix enriched with membrane metalloendopeptidase and insulin-degrading enzyme suppresses the deposition of amyloid-beta peptide in Alzheimer's disease cell models.
Zhang S; Xiao T; Yu Y; Qiao Y; Xu Z; Geng J; Liang Y; Mei Y; Dong Q; Wang B; Wei J; Suo G
J Tissue Eng Regen Med; 2019 Oct; 13(10):1759-1769. PubMed ID: 31151136
[TBL] [Abstract][Full Text] [Related]
2. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation.
Qiu WQ; Walsh DM; Ye Z; Vekrellis K; Zhang J; Podlisny MB; Rosner MR; Safavi A; Hersh LB; Selkoe DJ
J Biol Chem; 1998 Dec; 273(49):32730-8. PubMed ID: 9830016
[TBL] [Abstract][Full Text] [Related]
3. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
[TBL] [Abstract][Full Text] [Related]
4. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
[TBL] [Abstract][Full Text] [Related]
5. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
Liu Y; Hua Q; Lei H; Li P
J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326
[TBL] [Abstract][Full Text] [Related]
6. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
Yang H; Yang H; Xie Z; Wang P; Bi J
Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
[TBL] [Abstract][Full Text] [Related]
7. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
8. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
Stargardt A; Gillis J; Kamphuis W; Wiemhoefer A; Kooijman L; Raspe M; Benckhuijsen W; Drijfhout JW; Hol EM; Reits E
Aging Cell; 2013 Jun; 12(3):499-507. PubMed ID: 23534431
[TBL] [Abstract][Full Text] [Related]
9. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
Qiu WQ; Folstein MF
Neurobiol Aging; 2006 Feb; 27(2):190-8. PubMed ID: 16399206
[TBL] [Abstract][Full Text] [Related]
10. Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease.
Dorfman VB; Pasquini L; Riudavets M; López-Costa JJ; Villegas A; Troncoso JC; Lopera F; Castaño EM; Morelli L
Neurobiol Aging; 2010 Oct; 31(10):1743-57. PubMed ID: 19019493
[TBL] [Abstract][Full Text] [Related]
11. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
12. The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme: a biological perspective.
de Tullio MB; Morelli L; Castaño EM
Prion; 2008; 2(2):51-6. PubMed ID: 19098445
[TBL] [Abstract][Full Text] [Related]
13. Powering Amyloid Beta Degrading Enzymes: A Possible Therapy for Alzheimer's Disease.
Sikanyika NL; Parkington HC; Smith AI; Kuruppu S
Neurochem Res; 2019 Jun; 44(6):1289-1296. PubMed ID: 30806879
[TBL] [Abstract][Full Text] [Related]
14. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ
PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279
[TBL] [Abstract][Full Text] [Related]
15. Insulysin: an allosteric enzyme as a target for Alzheimer's disease.
Song ES; Hersh LB
J Mol Neurosci; 2005; 25(3):201-6. PubMed ID: 15800373
[TBL] [Abstract][Full Text] [Related]
16. The Longest Amyloid-β Precursor Protein Intracellular Domain Produced with Aβ42 Forms β-Sheet-Containing Monomers That Self-Assemble and Are Proteolyzed by Insulin-Degrading Enzyme.
Krasinski CA; Zheng Q; Ivancic VA; Spratt DE; Lazo ND
ACS Chem Neurosci; 2018 Dec; 9(12):2892-2897. PubMed ID: 30067897
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM
FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174
[TBL] [Abstract][Full Text] [Related]
18. Activated protein C inhibits amyloid β production via promoting expression of ADAM-10.
Li B; Yu D; Xu Z
Brain Res; 2014 Jan; 1545():35-44. PubMed ID: 24333930
[TBL] [Abstract][Full Text] [Related]
19. A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.
Wei L; Yang H; Xie Z; Yang S; Yang H; Zhao C; Wang P; Xu S; Miao J; Zhao B; Bi J
J Alzheimers Dis; 2012; 30(3):531-43. PubMed ID: 22451314
[TBL] [Abstract][Full Text] [Related]
20. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress.
de Dios C; Bartolessis I; Roca-Agujetas V; Barbero-Camps E; Mari M; Morales A; Colell A
Redox Biol; 2019 Sep; 26():101283. PubMed ID: 31376793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
